Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced its 2025 annual results, highlighting a year of comprehensive, ...

The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.

The program leverages Just - Evotec Biologics' advanced biomanufacturing platform to deliver high-quality, scalable, cost-efficient production through significantly higher yieldsManufacturing process ...

EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...

Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score Pharma, Inc., a biopharmaceutical company ...

Biobots, whose growing line of variants started with xenobots, are fascinating tiny self-powered living robots built ...

Scientists at UCSF invented a microscopic “womb” material for growing artificial organs (organoids) from scratch.

Methods developed and validated to establish the "World Bank of NK Cells" from healthy donors and cancer patients -- Single apheresis yields up to 5 billion (5×109) highly pure activated memory ...

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...

Think about your favorite medicine. Maybe it is a vaccine or a powerful antibody. Have you ever wondered how it is made? It does not come from a chemical plant. It often comes from living cells.

Professor of Nanoscale Science and Engineering, Fulbright Global Scholar, College of Nanotechnology, Science & Engineering, University at Albany, State University of New York As demand for recombinant ...